BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 1, 2022
View Archived Issues
CRV-431 is a possible treatment approach for ALD
Read More
Thrombospondin-1 found to be involved in pathogenesis of acute-on-chronic liver failure
Read More
Albireo patents SLC10A1 and/or SLC10A2 inhibitors
Read More
Qurient Therapeutics discloses new CDK7 inhibitors
Read More
Tuojie Biotech identifies new P2X3 antagonists
Read More
Stingray Therapeutics synthesizes ENPP1 inhibitors
Read More
Roche discovers new EGFR mutant inhibitors for NSCLC
Read More
KLB as a novel druggable target for the prevention of NAFLD
Read More
CSF1R inhibition could delay muscular dystrophy progression
Read More
Extended funding supports Errium's development of therapeutics for chronic autoimmune diseases
Read More
Ildong licenses Twist VHH antibody libraries for antibody discovery in immuno-oncology
Read More
China NMPA approves IND for Henlius' anti-TIGIT Fc fusion protein HLX-53
Read More
Anti-alpha-1-antitrypsin BMN-349 reverses liver disease in a preclinical model
Read More
Sutro Biopharma generates hemiasterlin/TLR agonist dual-conjugate anti-FolR-alpha ADCs
Read More
ENT1 inhibitor reverses sporadic Alzheimer's disease in mice
Read More
